Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Characteristics of 5 TB subjects with persistent positive IGRA results and less good outcome.

Ilaria Sauzullo (351330)
Fabio Mengoni (338004)
Miriam Lichtner (338007)
Anna Paola Massetti (373440)
Raffaella Rossi (208574)
Marco Iannetta (373441)
Raffaella Marocco (351324)
Cosmo Del Borgo (351327)
Fabrizio Soscia (237796)
Vincenzo Vullo (338008)
Claudio Maria Mastroianni (373442)

Publication date

February 2013

DOI

10.1371/journal.pone.0005187.t003

Abstract

<p><b>Abbreviations:</b></p><p>ND: not done; INH : Isoniazid; RIF: rifampicin.</p

Extracted data

Related items

Diagnostic accuracy of BAL IGRA.

Adithya Cattamanchi (121837)
Isaac Ssewenyana (318064)
Rose Nabatanzi (318066)
Cecily R. Miller (318068)
Saskia Den Boon (5652115)
J. Lucian Davis (121838)
Alfred Andama (121846)
William Worodria (121839)
Samuel D. Yoo (298397)
Huyen Cao (318069)
Laurence Huang (121862)

February 2013

*<p> <b>% (95% confidence interval); indeterminate IGRA results excluded.</b></p><p>...

Associations between Patient Characteristics and Prevalence of Active TB at ART Initiation.

Andrew F. Auld (287782)
Francisco Mbofana (287784)
Ray W. Shiraishi (282434)
Charity Alfredo (287786)
Mauro Sanchez (287788)
Tedd V. Ellerbrock (287790)
Lisa J. Nelson (287791)

February 2013

<p>Abbreviations: TB, tuberculosis; ART, antiretroviral therapy; IQR, inter-quartile range; CI, 95% ...

The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India

Deepa Dorai
Achanta Shanta
Jaju Jyoti
Rao Koteswara
Samyukta Rani
Claassens Mareli
Kumar Ajay M. V.
PH Vishnu

October 2013

; H-Isoniazid; R-Rifampicin; Z-Pyrazinamide; E-Ethambutol; S-Streptomycin) may be inadequate to trea...

Characteristics of final TB patient sample at TB treatment start, ART exposure and TB treatment duration.

Lenka Benova (168877)
Katherine Fielding (168885)
Jane Greig (168891)
Bern-Thomas Nyang'wa (168896)
Esther Carrillo Casas (168899)
Marcio Silveira da Fonseca (168902)
Philipp du Cros (168905)

April 2012

*<p>2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 month...

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015

Duc T. Nguyen
Larry D. Teeter
Julie Graves
Edward A. Graviss

March 2018

Interferon-γ release assays (IGRAs) are the preferred diagnostic test for tuberculosis (TB) infectio...

IGRA screening in biologics: safe and reliable, but not perfect

Cafferkey, J
Padayachee, Y
Kostich, S
Kumar, K
Jewell, P
Patel, M
Chavda, A
Cox, A
Park, M
Russell, G
Coleman, M
Martin, L
Kon, O

August 2022

Introduction Systemic biologic agents can increase the risk of reactivation of latent tuberculosis (...

End of Treatment Outcomes for Isoniazid and Rifampicin Mono-resistant TB Cases.

Leonela Villegas (2590909)
Larissa Otero (308500)
Timothy R. Sterling (148936)
Moises A. Huaman (2590906)
Patrick Van der Stuyft (154687)
Eduardo Gotuzzo (20728)
Carlos Seas (308510)

April 2016

<p>End of Treatment Outcomes for Isoniazid and Rifampicin Mono-resistant TB Cases.</p

Demographic and clinical characteristics of patients.

Viral Vadwai (344411)
Gustad Daver (344412)
Zarir Udwadia (316426)
Meeta Sadani (344413)
Anjali Shetty (287809)
Camilla Rodrigues (287811)

February 2013

a<p>All patients were HIV negative.</p>b<p>All patients received treatment from private medical prac...

Sensitivity, specificity, positive predictive value, negative predictive value and analytic accuracy of IGRA in culture-positive or culture-negative TB patients.

Marcin Wlodarczyk (629661)
Wieslawa Rudnicka (629662)
Beata Janiszewska-Drobinska (629663)
Grzegorz Kielnierowski (629664)
Magdalena Kowalewicz-Kulbat (629665)
Marek Fol (261496)
Magdalena Druszczynska (629666)

September 2014

<p>IGRA, interferon-gamma release assay; PPV, <i>positive predicted value</i>; NPV, <i>negative pred...

Emerg Infect Dis

Interferon-\u3b3 release assays (IGRAs) are the preferred diagnostic test for tuberculosis (TB) infe...

Comparisons of progression of tuberculosis in HIV-infected patients with interferon-gamma release assay testing.

Hsin-Yun Sun (61134)
Po-Ren Hsueh (129731)
Wen-Chun Liu (61140)
Yi-Ching Su (734372)
Sui-Yuan Chang (39460)
Chien-Ching Hung (61132)
Shan-Chwen Chang (91714)

May 2015

<p><b>Note:</b></p><p><sup>1</sup>Patient No.: patient number after exclusion of patients with activ...

Selected demographic characteristics of study patients.

Gabriela Carriquiry (199604)
Larissa Otero (308500)
Elsa González-Lagos (308503)
Carlos Zamudio (197329)
Eduardo Sánchez (308506)
Pamela Nabeta (121852)
Miguel Campos (296813)
Juan Echevarría (308509)
Carlos Seas (308510)
Eduardo Gotuzzo (20728)

February 2013

<p>IQR: interquartile range; TB: tuberculosis; HAART: Highly active antiretroviral therapy.</p>*<p>E...

Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis

Wang Tsai-Yu
Lin Shu-Min
Shie Shian-Sen
Chou Pai-Chien
Huang Chien-Da
Chung Fu-Tsai
Kuo Chih-His
Chang Po-Jui
Kuo Han-Pin

January 2014

Isoniazid (INH) resistance is now the most common type of tuberculosis (TB) infection resistance wor...

Univariable and multivariable associations with unsuccessful treatment outcome.

Tsai-Yu Wang (194895)
Shu-Min Lin (130229)
Shian-Sen Shie (364971)
Pai-Chien Chou (130227)
Chien-Da Huang (308378)
Fu-Tsai Chung (176927)
Chih-His Kuo (513019)
Po-Jui Chang (420390)
Han-Pin Kuo (130254)

January 2014

<p>Abbreviations: INH: isoniazid; AFB: acid fast bacilli; CI: confidence interval.</p

Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon gamma response at the time of diagnosis

Matsushita, Ikumi
Hang, Nguyen Thi Le
Hong, Le Thi
Tam, Do Bang
Lien, Luu Thi
Thuong, Pham Huu
Cuong, Vu Cao
Hijikata, Minako
Kobayashi, Nobuyuki
Sakurada, Shinsaku
Higuchi, Kazue
Harada, Nobuyuki
Keicho, Naoto

November 2015

SummaryObjectivesIn the performance of interferon gamma release assays (IGRA) for the diagnosis of t...

Diagnostic accuracy of BAL IGRA.

Adithya Cattamanchi (121837)
Isaac Ssewenyana (318064)
Rose Nabatanzi (318066)
Cecily R. Miller (318068)
Saskia Den Boon (5652115)
J. Lucian Davis (121838)
Alfred Andama (121846)
William Worodria (121839)
Samuel D. Yoo (298397)
Huyen Cao (318069)
Laurence Huang (121862)

February 2013

*<p> <b>% (95% confidence interval); indeterminate IGRA results excluded.</b></p><p>...

Associations between Patient Characteristics and Prevalence of Active TB at ART Initiation.

Andrew F. Auld (287782)
Francisco Mbofana (287784)
Ray W. Shiraishi (282434)
Charity Alfredo (287786)
Mauro Sanchez (287788)
Tedd V. Ellerbrock (287790)
Lisa J. Nelson (287791)

February 2013

<p>Abbreviations: TB, tuberculosis; ART, antiretroviral therapy; IQR, inter-quartile range; CI, 95% ...

The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India

Deepa Dorai
Achanta Shanta
Jaju Jyoti
Rao Koteswara
Samyukta Rani
Claassens Mareli
Kumar Ajay M. V.
PH Vishnu

October 2013

; H-Isoniazid; R-Rifampicin; Z-Pyrazinamide; E-Ethambutol; S-Streptomycin) may be inadequate to trea...

Characteristics of final TB patient sample at TB treatment start, ART exposure and TB treatment duration.

Lenka Benova (168877)
Katherine Fielding (168885)
Jane Greig (168891)
Bern-Thomas Nyang'wa (168896)
Esther Carrillo Casas (168899)
Marcio Silveira da Fonseca (168902)
Philipp du Cros (168905)

April 2012

*<p>2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 month...

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015

Duc T. Nguyen
Larry D. Teeter
Julie Graves
Edward A. Graviss

March 2018

Interferon-γ release assays (IGRAs) are the preferred diagnostic test for tuberculosis (TB) infectio...

IGRA screening in biologics: safe and reliable, but not perfect

Cafferkey, J
Padayachee, Y
Kostich, S
Kumar, K
Jewell, P
Patel, M
Chavda, A
Cox, A
Park, M
Russell, G
Coleman, M
Martin, L
Kon, O

August 2022

Introduction Systemic biologic agents can increase the risk of reactivation of latent tuberculosis (...

End of Treatment Outcomes for Isoniazid and Rifampicin Mono-resistant TB Cases.

Leonela Villegas (2590909)
Larissa Otero (308500)
Timothy R. Sterling (148936)
Moises A. Huaman (2590906)
Patrick Van der Stuyft (154687)
Eduardo Gotuzzo (20728)
Carlos Seas (308510)

April 2016

<p>End of Treatment Outcomes for Isoniazid and Rifampicin Mono-resistant TB Cases.</p

Demographic and clinical characteristics of patients.

Viral Vadwai (344411)
Gustad Daver (344412)
Zarir Udwadia (316426)
Meeta Sadani (344413)
Anjali Shetty (287809)
Camilla Rodrigues (287811)

February 2013

a<p>All patients were HIV negative.</p>b<p>All patients received treatment from private medical prac...

Sensitivity, specificity, positive predictive value, negative predictive value and analytic accuracy of IGRA in culture-positive or culture-negative TB patients.

Marcin Wlodarczyk (629661)
Wieslawa Rudnicka (629662)
Beata Janiszewska-Drobinska (629663)
Grzegorz Kielnierowski (629664)
Magdalena Kowalewicz-Kulbat (629665)
Marek Fol (261496)
Magdalena Druszczynska (629666)

September 2014

<p>IGRA, interferon-gamma release assay; PPV, <i>positive predicted value</i>; NPV, <i>negative pred...

Emerg Infect Dis

Interferon-\u3b3 release assays (IGRAs) are the preferred diagnostic test for tuberculosis (TB) infe...

Comparisons of progression of tuberculosis in HIV-infected patients with interferon-gamma release assay testing.

Hsin-Yun Sun (61134)
Po-Ren Hsueh (129731)
Wen-Chun Liu (61140)
Yi-Ching Su (734372)
Sui-Yuan Chang (39460)
Chien-Ching Hung (61132)
Shan-Chwen Chang (91714)

May 2015

<p><b>Note:</b></p><p><sup>1</sup>Patient No.: patient number after exclusion of patients with activ...

Selected demographic characteristics of study patients.

Gabriela Carriquiry (199604)
Larissa Otero (308500)
Elsa González-Lagos (308503)
Carlos Zamudio (197329)
Eduardo Sánchez (308506)
Pamela Nabeta (121852)
Miguel Campos (296813)
Juan Echevarría (308509)
Carlos Seas (308510)
Eduardo Gotuzzo (20728)

February 2013

<p>IQR: interquartile range; TB: tuberculosis; HAART: Highly active antiretroviral therapy.</p>*<p>E...

Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis

Wang Tsai-Yu
Lin Shu-Min
Shie Shian-Sen
Chou Pai-Chien
Huang Chien-Da
Chung Fu-Tsai
Kuo Chih-His
Chang Po-Jui
Kuo Han-Pin

January 2014

Isoniazid (INH) resistance is now the most common type of tuberculosis (TB) infection resistance wor...

Univariable and multivariable associations with unsuccessful treatment outcome.

Tsai-Yu Wang (194895)
Shu-Min Lin (130229)
Shian-Sen Shie (364971)
Pai-Chien Chou (130227)
Chien-Da Huang (308378)
Fu-Tsai Chung (176927)
Chih-His Kuo (513019)
Po-Jui Chang (420390)
Han-Pin Kuo (130254)

January 2014

<p>Abbreviations: INH: isoniazid; AFB: acid fast bacilli; CI: confidence interval.</p

Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon gamma response at the time of diagnosis

Matsushita, Ikumi
Hang, Nguyen Thi Le
Hong, Le Thi
Tam, Do Bang
Lien, Luu Thi
Thuong, Pham Huu
Cuong, Vu Cao
Hijikata, Minako
Kobayashi, Nobuyuki
Sakurada, Shinsaku
Higuchi, Kazue
Harada, Nobuyuki
Keicho, Naoto

November 2015

SummaryObjectivesIn the performance of interferon gamma release assays (IGRA) for the diagnosis of t...

Diagnostic accuracy of BAL IGRA.

Adithya Cattamanchi (121837)
Isaac Ssewenyana (318064)
Rose Nabatanzi (318066)
Cecily R. Miller (318068)
Saskia Den Boon (5652115)
J. Lucian Davis (121838)
Alfred Andama (121846)
William Worodria (121839)
Samuel D. Yoo (298397)
Huyen Cao (318069)
Laurence Huang (121862)

February 2013

*<p> <b>% (95% confidence interval); indeterminate IGRA results excluded.</b></p><p>...

Associations between Patient Characteristics and Prevalence of Active TB at ART Initiation.

Andrew F. Auld (287782)
Francisco Mbofana (287784)
Ray W. Shiraishi (282434)
Charity Alfredo (287786)
Mauro Sanchez (287788)
Tedd V. Ellerbrock (287790)
Lisa J. Nelson (287791)

February 2013

<p>Abbreviations: TB, tuberculosis; ART, antiretroviral therapy; IQR, inter-quartile range; CI, 95% ...

The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India

Deepa Dorai
Achanta Shanta
Jaju Jyoti
Rao Koteswara
Samyukta Rani
Claassens Mareli
Kumar Ajay M. V.
PH Vishnu

October 2013

; H-Isoniazid; R-Rifampicin; Z-Pyrazinamide; E-Ethambutol; S-Streptomycin) may be inadequate to trea...